US8984021027 - Common Stock - After market: 36.35 0 (0%)
CTO Andrew Toy's innovations like Clover Assistant, seen by some as savior of CLOV stock, are already being adopted by larger Medicare Advantage players.
TRMK earnings call for the period ending September 30, 2021.
Trustmark (TRMK) delivered earnings and revenue surprises of 0.00% and 0.58%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Trustmark (TRMK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.